USA Randy Pritchard, General Manager and Senior Vice President of Clinical Operations for North America at bioMérieux, a global leader in in vitro diagnostics, speaks about the outsized strategic weight of the North American market, which accounts for nearly half of the company’s global revenue and a third of its workforce.…
Taiwan A genuinely healthy lifestyle can help prevent neurodegenerative disease Charles S.Y. Yang discusses how his background in physics and quantum sensing led to the founding of MagQu, pioneering ultra-sensitive blood biomarker diagnostics for Alzheimer’s and other neurodegenerative diseases. He explains the company’s SQUID-based technology, commercial journey, regulatory ambitions and funding…
Germany Money follows the science, and the science here in Bavaria is excellent Ralf Huss, Chief Executive of BioM, discusses how Bavaria has built one of Europe’s leading biotechnology ecosystems by connecting researchers, entrepreneurs, investors and global pharmaceutical companies. He highlights BioM‘s role in supporting more than 500 companies, accelerating start-ups…
Korea But Korea is genuinely active, with strong resources – scientifically sound, capable, and very motivated Kyong Hwa Park, Professor of Medical Oncology at Korea University College of Medicine, reflects on Korea’s transformation into a global oncology research hub, highlighting the impact of the K-MASTER precision medicine initiative, advances in cancer…
Taiwan Dr. I-Shu Lee, founder and CEO of Vitae Biomedical, began his career as a postdoctoral researcher before making the uncommon leap from academic laboratory to entrepreneurship in 2019. Built around a proprietary urine-based protein detection technology for early cancer screening, Vitae Biomedical has already achieved commercial traction in Taiwan, partnering…
China Belief BioMed’s Co-Founder and CEO, Dr Jane Zheng, sets out an ambition to move gene therapy beyond scientific promise and into a scalable, globally accessible treatment model. Built on an AAV platform and supported by integrated manufacturing, the company is advancing from its haemophilia B proof of concept into broader…
France MaaT Pharma is entering a defining moment in its mission to bring microbiotherapies into areas of acute unmet need. Hervé Affagard recounts how a personal catalyst, an engineering mindset and early scientific partnerships shaped a platform now approaching its first potential approval for its first microbiome drug candidate. The journey…
France France is undergoing a quiet industrial renaissance in biomanufacturing, driven by a growing alignment between science, innovation, and policy. At the centre of this movement stands Laurent Lafferrère, CEO of France BioLead, who is leading efforts to structure the country’s ecosystem, foster collaboration, and attract sustainable investment. In this conversation,…
China Chinese biotech is booming, led by a generation of pioneering individuals at the forefront of science and business. A country once best known as a low-cost manufacturing destination for ‘me-too’ copycat medicines now accounts for over 28 percent of the global drug development pipeline. Western companies approaching patent cliffs…
Denmark Kasper Møller, Chief Technical Officer and General Manager of AGC Biologics Denmark, shares insights into the company’s strategic priorities and the role of its Copenhagen facility in AGC Biologics’ global network. Møller discusses the ongoing expansion of the site, the growing complexity of biologics manufacturing, and the evolving demands of…
Denmark Christian Houborg, General Manager and Senior Vice President of FUJIFILM Biotechnologies Denmark, shares how the Hillerød site has evolved from a legacy facility into a cornerstone of the company’s global CDMO network. From expanding capacity to embracing cutting-edge technologies like AI and digitalisation, FUJIFILM Biotechnologies is setting new standards for…
China 2024 marks a moment of inflection for Harbour BioMed, as the company collect the rewards of a strong global execution. In this interview, Dr Jingsong Wang reflects on the strategic, scientific, and operational advances shaping the company’s trajectory. With its proprietary HCAb platform at the core, Harbour BioMed is extending…
See our Cookie Privacy Policy Here
